comprehensive -WSS

comprehensive

author：hotspot 2025-09-27 06:03:08 - browse：3371

WASHINGTON, DC - NOVEMBER 27: U.S. President Joe Biden speaks about supply chain resilience during an event in the Indian Treaty Room at the Eisenhower Executive Office Building on November 27, 2023 in Washington, DC. — President Biden spoke about supply chain resilience and drug shortages. Alex Wong/Getty Images

WASHINGTON — President Biden’s new plan to curb drug shortages by boosting domestic drug production won’t expand the supply of the chemotherapies that are currently in shortage, an administration official confirmed. The limited scope surprised experts, who told STAT Biden could have included those drugs in the effort.

The 15 cancer drugs in short supply account for only a little more than 10% of the drugs on FDA’s shortage list. But chemotherapies are far more crucial than many other drugs experiencing shortages, which include injections of amino acids and multivitamins, and sterile water. Gut-wrenching stories about cancer patients being switched to less-effective drugs have caused cancer doctors to agitate for government solutions.

Biden announced last week that he plans to use the Defense Production Act to get companies to make essential medicines and their ingredients in the United States. The administration will spend $35 million to boost domestic production of key starting materials for drugs that hospitals commonly use and are prone to shortages.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Orchard's therapy for neuron disease in children wins FDA approval

WSS

First over

Families look for replacement for GSK asthma drug Flovent

Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee

Readout Newsletter: Bluebird, CVS, Contineum

UnitedHealth increases loan offers after Change Healthcare outage

Why Talkspace is targeting Medicare, a tricky market

knowledge

comprehensive

knowledge

Duchenne breakthrough therapy leaves behind pioneering families

Stop the failed accountable care organization experiment

DIEP, the 'gold standard' of breast reconstruction, is under threat

Microsoft's Peter Lee: Generative AI could help doctors be more human

Malaria cases in Florida and Texas: Here’s what you need to know

Future doctors should be trained to promote social change

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

SCOTUS questions limit to govt efforts to fight misinformation

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

hotspot

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

Readout Newsletter: Bluebird, CVS, Contineum

Intermittent fasting comes with a heart risk? Not so fast

Leading voice in opioid treatment defends methadone clinic system

Virtual Event: March of the Biosimilars

Nurses recount patients attacks

hotspot

leisure time

focus

Wikipedia